TF and glioblastoma: Furthermore, the application of transferrin-modified magnetic NPs has demonstrated the accumulation of siPLK1 within the brain tissue of glioblastoma-bearing mice, together with a significant reduction in the tumor mass and improved survival of the mice [68].